Previous Close | 9.29 |
Open | 9.40 |
Bid | 0.00 x 3100 |
Ask | 0.00 x 1400 |
Day's Range | 9.32 - 9.54 |
52 Week Range | 6.68 - 19.48 |
Volume | |
Avg. Volume | 1,996,129 |
Market Cap | 944.98M |
Beta (5Y Monthly) | 1.21 |
PE Ratio (TTM) | 6.67 |
EPS (TTM) | 1.42 |
Earnings Date | Apr 30, 2024 - May 06, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Feb 28, 2014 |
1y Target Est | 12.50 |
Herbalife's struggles with legal battles, mounting debt, and slowing earnings per share casts a shadow over its future prospects. The company's controversial business model and poor performance suggest ongoing challenges ahead.
LOS ANGELES, March 22, 2024--Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community and platform, today announced the initiation of a refinancing process for its 2018 Term Loan B, which matures in August 2025. As of December 31, 2023, $650.6 million was outstanding under the Term Loan B. The previously announced refinancing of the Company’s 2018 Term Loan A and 2018 Revolving Credit Facility is ongoing.
LOS ANGELES, March 20, 2024--Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community and platform, today announced the appointment of John DeSimone as Chief Financial Officer, succeeding Alex Amezquita who will remain with the Company. Mr. DeSimone has been an executive at Herbalife for the past 17 years, including more than 8 years as CFO from 2010 – 2018 and 4 years as President and Co-President from 2018 – 2022. Most recently, he served as a Special Advisor to the CEO.